ORIGINAL RESEARCH
Accepted on 06 Aug 2025
Post-Marketing Safety Surveillance of Pneumococcal Vaccines: A Real-World Pharmacovigilance Study Using the U.S. Vaccine Adverse Event Reporting System (VAERS) Database
doi 10.3389/fcimb.2025.1635180
- 258 views